White Marvin L 4
4 · Aptevo Therapeutics Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
White Marvin L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-03-03+6→ 55 total - Exercise/Conversion
Restricted Stock Unit
2025-03-03−6→ 0 total→ Common Stock (6 underlying) - Exercise/Conversion
Common Stock
2025-03-02+8→ 49 total - Exercise/Conversion
Restricted Stock Unit
2025-03-02−8→ 8 total→ Common Stock (8 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On March 3, 2023, the reporting person was granted 38,750 (24 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
- [F3]On June 7, 2022, the reporting person was granted 28,750 (18 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.